Cardiopulmonary arrest following administration of Cyclomydril eyedrops for outpatient retinopathy of prematurity screening

Eyedrops used for mydriasis and cycloplegia can be systemically absorbed, causing serious side effects, including oxygen desaturation, apnea, bradycardia, transient hypertension, delayed gastric emptying, and transient paralytic ileus. These effects can be more serious in infants because of their lo...

Full description

Saved in:
Bibliographic Details
Published inJournal of AAPOS Vol. 18; no. 2; pp. 183 - 184
Main Authors Lee, Jung M., MD, Kodsi, Sylvia R., MD, Gaffar, Majida A., MD, Rubin, Steven E., MD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.04.2014
Subjects
Cardiopulmonary Resuscitation
Cyclopentolate - adverse effects
Drug Combinations
Female
Gestational Age
Heart Arrest - chemically induced
Heart Arrest - therapy
Humans
Infant
Mydriatics - adverse effects
Ophthalmic Solutions
Ophthalmology
Outpatients
Phenylephrine - adverse effects
Retinopathy of Prematurity - diagnosis
Online AccessGet full text

Cover

More Information
Summary:Eyedrops used for mydriasis and cycloplegia can be systemically absorbed, causing serious side effects, including oxygen desaturation, apnea, bradycardia, transient hypertension, delayed gastric emptying, and transient paralytic ileus. These effects can be more serious in infants because of their lower body mass and immature cardiovascular and nervous systems. We report a case of a 27-week-old infant who suffered a cardiopulmonary arrest after the administration of only Cyclomydril eyedrops (Alcon Laboratories, Fort Worth, TX) during an outpatient retinopathy of prematurity examination.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1091-8531
1528-3933
DOI:10.1016/j.jaapos.2013.11.010